Haystack Oncology, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-16. The offering totals $67.0M, of which $67.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Dan Edelstein | Director | BALTIMORE, MD |
| Nickolas Papadopoulos | Director | BALTIMORE, MD |
| George Petrocheilos | Director | Baltimore, MD |
| Isaac Ro | Director | San Mateo, CA |
| R. Jacob Vogelstein | Director | Cambridge, MA |
| Dan Edelstein | Executive Officer | BALTIMORE, MD |
| Olga Maltseva | Executive Officer | New York, NY |
| Nickolas Papadopoulos | Executive Officer | BALTIMORE, MD |